We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congressional Fix For Follow-On Biologics Unlikely Until 2008
Congressional Fix For Follow-On Biologics Unlikely Until 2008
June 23, 2006
Any legislative fix to the current FDA approval process for follow-on biologics is likely at least two years away because of other legislative priorities and the need for lawmakers to get up to speed on this issue, a Senate staffer says.